My Treatment Approach: Recent Advances in the Treatment of Multiple Myeloma in Early Relapse : Episode 8
Video
CANDOR Trial of Daratumumab Plus Carfilzomib and Dexamethasone in R/R MM
Author(s):
Brea Lipe, MD, and Peter Forsberg, MD, review the results of the CANDOR trial evaluating DARA-Kd regimen in R/R multiple myeloma.
EP: 1.Patient Profile 1: A 63-Year-Old Female with Relapsed Multiple Myeloma
EP: 2.Treatment Options for Patients with Multiple Myeloma in Early Relapse
EP: 3.IKEMA Trial of Isatuximab plus Carfilzomib and Dexamethasone in R/R MM
EP: 4.Clinical Implications of the IKEMA Trial in R/R MM
EP: 5.Selecting the Appropriate Patients With MM for Treatment With Isa-Kd
EP: 6.Treatment of Patients With MM and High-Risk Cytogenetics
EP: 7.Patient Profile 2: A 76-Year-Old Female with R/R MM
Now Viewing
EP: 8.CANDOR Trial of Daratumumab Plus Carfilzomib and Dexamethasone in R/R MM
EP: 9.Selecting Patients for Treatment With DARA-Kd
EP: 10.Sequencing Therapies in Patients With R/R MM
EP: 11.Advice for Community Oncologists Treating Patients With R/R MM
Related Videos
Related Content
